Allergy

Biosimilars

Cardiology

Dermatology

Endocrinology

Family Medicine

Gastroenterology

Geriatrics

Hospital Medicine

Infectious Disease

Internal Medicine

Nephrology

Neurology

Obesity Management

Ophthalmology

Pain

Pediatrics

Psychiatry

Pulmonology

Rare Disease Report®

Rheumatology

Sleep

Surgery

Women's Health

News

Media

Medical World News

Podcasts

Shows

State Of Sciences - Presentations

Videos

Webinars

Multimedia Series

Insights

Medcast Podcasts

Medcast Videos

Peer Exchange

Peers & Perspectives

Conferences

Conference Coverage

Conference Listing

Partners

CME/CE

Resources

Interactive Tools

Live Events

Press Release

Publications

Subscribe

Lana Pine is the editor of HCPLive Rheumatology. She is an experienced editor and technical writer with a demonstrated history of working in the banking and publishing industries. In her free time, she enjoys cooking, yoga, listening to podcasts, and drawing. She can be reached via email at LPine@mjhlifesciences.com.

Articles

Results may help minimize the risk of developing hyperuricemia, gout, and related adverse events in patients receiving antihypertensive drugs.

Certain Antihypertensive Drugs may Increase Risk of Hyperuricemia, Gout

The positivity rate of rhinoviruses and enteroviruses decreased briefly following the onset of the COVID-19 pandemic, but by fall of 2020 resumed almost to pre-pandemic levels. 

Acute Respiratory Illness in Pediatric Patients Before and During COVID-19 Pandemic

Connor Iapoce is an associate editor for 

 and joined the MJH Life Sciences team in April 2021. He graduated from The College of New Jersey with a degree in Journalism and Professional Writing. He enjoys listening to records, going to concerts, and playing with his cat Squish. You can reach him at 

New 6-month findings from a First-in-Human glaucoma treatment trial indicate the drug delivery platform continued to show a 45% reduction in mean intraocular pressure. 

Malik Kahook, MD: Updates on SpyGlass Platform for Glaucoma Treatment

Brian LaMoreaux, MD, MS, is a rheumatologist and Senior Medical Director at Horizon Therapeutics. 

As an industry and a society, we must take gout more seriously. That effort begins with the physicians who diagnose and treat it. 

Gout Isn’t a Punchline. It’s Time to Stop Treating it Like One. 

HCPLive is a comprehensive clinical news and information portal that provides physicians with up-to-date specialty and disease-specific resources designed to help them provide better care to patients. At HCPLive, you will find breaking news, video interviews with physician experts, in-depth conference coverage, finance and practice management updates, insight and analysis from physician contributors, and more.

About Us

Advertise

Editorial

Contact Us

Do Not Sell My Information

Privacy

Terms & Conditions

HCPLive - Clinical news for connected physicians

Facebook

Twitter

LinkedIn

Spotlight

Biosimilars Spotlight

COVID-19

Qazi Corner

This Year In Medicine 2022

Clinical

ADHD

Arterial Disease

Diabetes

Geriatric Medicine

Video Series

News Network

Post Conference Perspectives

Journals

Bench to Bedside in Cardiology®

Rapid Reviews in Cardiology®

Surgical Rounds®

Resident & Staff Physician®

Peers & Perspectives®

MD Net Guide Newsletter

MD Magazine®

Hemophilia Reports

DO Net Guide

Cardiology Review® Online

MD Magazine Neurology

MD Magazine Cardiology

Targeted Therapies: Multiple Sclerosis

Targeted Therapies: Hepatitis C

Internal Medicine World Report

Family Practice Recertification

Contagion

Targeted Therapies: Arthritis

Physician's Money Digest

Pain Management

MDNG Primary Care

MDNG Pediatrics

MDNG Pain Management

MDNG Neurology

MDNG Hospital Medicine

ONCNG Oncology Nursing

ONCNG Oncology

OBTN

MDNG Psychiatry

MDNG Endocrinology

FOCUS Multicultural Healthcare

DIALOGS Bipolar Depression

FOCUS Cardiometabolic Risk

DIALOGS Bipolar Disorder

DIALOGS ADHD

Advances In Addiction Treatment

Supplements

Journals

Legacy